These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24304719)

  • 1. Lack of dopamine D4 receptor affinity contributes to the procognitive effect of lurasidone.
    Murai T; Nakako T; Ikeda K; Ikejiri M; Ishiyama T; Taiji M
    Behav Brain Res; 2014 Mar; 261():26-30. PubMed ID: 24304719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lurasidone on executive function in common marmosets.
    Murai T; Nakako T; Ikejiri M; Ishiyama T; Taiji M; Ikeda K
    Behav Brain Res; 2013 Jun; 246():125-31. PubMed ID: 23454675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D
    Miyauchi M; Neugebauer NM; Meltzer HY
    J Psychopharmacol; 2017 Apr; 31(4):442-452. PubMed ID: 28347261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
    Ishibashi T; Horisawa T; Tokuda K; Ishiyama T; Ogasa M; Tagashira R; Matsumoto K; Nishikawa H; Ueda Y; Toma S; Oki H; Tanno N; Saji I; Ito A; Ohno Y; Nakamura M
    J Pharmacol Exp Ther; 2010 Jul; 334(1):171-81. PubMed ID: 20404009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serotonin 5-HT₁A receptor agonist tandospirone improves executive function in common marmosets.
    Baba S; Murai T; Nakako T; Enomoto T; Ono M; Shimizu I; Ikeda K
    Behav Brain Res; 2015; 287():120-6. PubMed ID: 25804359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical antipsychotic blonanserin reverses (+)-PD-128907- and ketamine-induced deficit in executive function in common marmosets.
    Kotani M; Enomoto T; Murai T; Nakako T; Iwamura Y; Kiyoshi A; Matsumoto K; Matsumoto A; Ikejiri M; Nakayama T; Ogi Y; Ikeda K
    Behav Brain Res; 2016 May; 305():212-7. PubMed ID: 26970575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
    Huang M; Horiguchi M; Felix AR; Meltzer HY
    Neuroreport; 2012 May; 23(7):436-40. PubMed ID: 22415605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone.
    Horisawa T; Nishikawa H; Toma S; Ikeda A; Horiguchi M; Ono M; Ishiyama T; Taiji M
    Behav Brain Res; 2013 May; 244():66-9. PubMed ID: 23376699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
    Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
    J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
    Ishiyama T; Tokuda K; Ishibashi T; Ito A; Toma S; Ohno Y
    Eur J Pharmacol; 2007 Oct; 572(2-3):160-70. PubMed ID: 17662268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of dopamine D₂/D₃ and serotonin 5-HT₂A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography.
    Nakazawa S; Yokoyama C; Nishimura N; Horisawa T; Kawasaki A; Mizuma H; Doi H; Onoe H
    Psychopharmacology (Berl); 2013 Jan; 225(2):329-39. PubMed ID: 22868411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical arguments for the use of dopamine D
    Huang M; Kwon S; He W; Meltzer HY
    Pharmacol Biochem Behav; 2017 Jun; 157():16-23. PubMed ID: 28455126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
    Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and neurophysiological effects of Ro 10-5824, a dopamine D4 receptor partial agonist, in common marmosets.
    Nakazawa S; Murai T; Miyauchi M; Kotani M; Ikeda K
    Psychopharmacology (Berl); 2015 Sep; 232(17):3287-95. PubMed ID: 26041337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lurasidone: an atypical antipsychotic for schizophrenia.
    Risbood V; Lee JR; Roche-Desilets J; Fuller MA
    Ann Pharmacother; 2012; 46(7-8):1033-46. PubMed ID: 22828971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lurasidone: a new drug in development for schizophrenia.
    Meyer JM; Loebel AD; Schweizer E
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1715-26. PubMed ID: 19780705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses.
    Yuen EY; Li X; Wei J; Horiguchi M; Meltzer HY; Yan Z
    Mol Pharmacol; 2012 Feb; 81(2):113-9. PubMed ID: 22072817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomical specificity in the modulation of activity-regulated genes after acute or chronic lurasidone treatment.
    Luoni A; Rocha FF; Riva MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():94-101. PubMed ID: 24361635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.